Hartmut Beug
- Oncology top 0.1%
- Cytokine Signaling Pathways and Interactions 34
- Cancer Cells and Metastasis 28
- Molecular Biology top 0.1%
- TGF-β signaling in diseases 16
- Wnt/β-catenin signaling in development and cancer 15
- Cancer Research top 0.2%
- Cell Biology top 0.2%
- Immunology top 0.5%
-
- Erythrocyte Function and Pathophysiology 43
-
- Virus-based gene therapy research 43
- Hemoglobinopathies and Related Disorders 13
-
- Animal Virus Infections Studies 24
- Co-authors
- Thomas GrafMargit A. HuberNorbert KrautStefan GrünertMartin JechlingerMichael J. HaymanMartin ZenkeWolfgang Mikulits
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Hartmut Beug
254 papers receiving 24.5k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 7.4k
- Molecular Biology 16.1k
- Cancer Research 3.4k
- Cell Biology 2.8k
- Immunology 3.4k
Countries citing papers authored by Hartmut Beug
This map shows the geographic impact of Hartmut Beug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Beug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Beug more than expected).
Fields of papers citing papers by Hartmut Beug
This network shows the impact of papers produced by Hartmut Beug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Beug. The network helps show where Hartmut Beug may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hartmut Beug, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 188 | |
| 2 | 2010 | 180 | |
| 3 | 2007 | 68 | |
| 4 | 2006 | 168 | |
| 5 | 2006 | 127 | |
| 6 | 2006 | 150 | |
| 7 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progressionbreakdown → | 2004 | 734 |
| 8 | 2001 | 280 | |
| 9 | 2000 | 58 | |
| 10 | Three-dimensional organotypic growth of epithelial cells in reconstituted extracellular matrix. | 1998 | 2 |
| 11 | 1997 | 28 | |
| 12 | 1996 | 4 | |
| 13 | 1995 | 46 | |
| 14 | 1994 | 28 | |
| 15 | The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation? | 1992 | 3 |
| 16 | Abnormal glycosylation of the env-sea oncogene product inhibits its proteolytic cleavage and blocks its transforming ability. | 1988 | 11 |
| 17 | 1986 | 18 | |
| 18 | 1985 | 8 | |
| 19 | 1980 | 6 | |
| 20 | 1977 | 23 |
About Hartmut Beug
Hartmut Beug is a scholar working on Oncology, Animal Science and Zoology and Genetics, having authored 254 papers that have together received 25.3k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (43 papers), Virus-based gene therapy research (43 papers), Cytokine Signaling Pathways and Interactions (34 papers), Cancer Cells and Metastasis (28 papers), Animal Virus Infections Studies (24 papers), TGF-β signaling in diseases (16 papers), Wnt/β-catenin signaling in development and cancer (15 papers) and Hemoglobinopathies and Related Disorders (13 papers). The work is most often cited by research in Oncology (7.4k citations), Molecular Biology (16.1k citations) and Cancer Research (3.4k citations). Hartmut Beug has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Thomas Graf, Margit A. Huber, Norbert Kraut, Stefan Grünert, Martin Jechlinger, Michael J. Hayman, Martin Zenke, Wolfgang Mikulits, Andreas Eger and Thomas Wirth. Their work appears in journals such as Oncogene, Blood, Cell, The EMBO Journal and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.